NCT05097378 Perioperative Encobini in BRAFV600 Mutant Stage III (B/C/D) or Oligometastatic Stage IV Melanoma Status UNKNOWN Phase PHASE2
NCT05094804 A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Status RECRUITING Phase PHASE1/PHASE2
NCT05087875 Evaluating an mHealth Intervention for Reducing Alcohol Use Among Adolescent and Young Adult Cancer Survivors Status COMPLETED Phase NA
NCT05083494 Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer. Status UNKNOWN Phase N/A
NCT05082701 Sentinel™ Trial: A Prospective Study Evaluating the Performance and Clinical Benefit of Personalized ctDNA-based MRD Testing to Detect Recurrence and Monitor Treatment Response in Patients With Solid Tumors Status TERMINATED Phase N/A
NCT05082610 A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT05080361 Rechallenge of BRAF +/- MEK Inhibitors Following an Adverse Event in Patients With Cancer Status UNKNOWN Phase N/A
NCT05078671 Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness Status RECRUITING Phase PHASE4
NCT05076916 The Effectiveness of the Web-based Education Programme Among Cancer Patients Status COMPLETED Phase NA
NCT05075538 COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2 Status TERMINATED Phase PHASE4
NCT05069662 Impact of the COVID-19 Pandemic on Drug Use and Monitoring of Cancer Patients Status COMPLETED Phase N/A
NCT05069519 Implementing Personalized Exercise Prescriptions Through Mobile Health in the Elderly Cancer Survivors Status COMPLETED Phase NA